First Time Loading...

Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 82.44 USD -1.62% Market Closed
Updated: May 5, 2024

Biomarin Pharmaceutical Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biomarin Pharmaceutical Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Cash from Investing Activities
-$95.5m
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
12%
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
-76%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$26.2B
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$3.2B
CAGR 3-Years
-256%
CAGR 5-Years
-17%
CAGR 10-Years
-25%

See Also

What is Biomarin Pharmaceutical Inc's Cash from Investing Activities?
Cash from Investing Activities
-95.5m USD

Based on the financial report for Mar 31, 2024, Biomarin Pharmaceutical Inc's Cash from Investing Activities amounts to -95.5m USD.

What is Biomarin Pharmaceutical Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
12%

Over the last year, the Cash from Investing Activities growth was 31%. The average annual Cash from Investing Activities growth rates for Biomarin Pharmaceutical Inc have been 22% over the past three years , and 12% over the past ten years .